Identification of the characteristics and prognostic impact of FUS::ERG and RUNX1::CBFA2T3 fusion genes in adult acute myeloid leukemia patients
- PMID: 38651500
- DOI: 10.1002/ajh.27340
Identification of the characteristics and prognostic impact of FUS::ERG and RUNX1::CBFA2T3 fusion genes in adult acute myeloid leukemia patients
References
REFERENCES
-
- Noort S, Zimmermann M, Reinhardt D, et al. Prognostic impact of t(16;21)(p11;q22) and t(16;21)(q24;q22) in pediatric AML: a retrospective study by the I‐BFM Study Group. Blood. 2018;132(15):1584‐1592.
-
- Liu H, Wang SA, Schlette EJ, et al. Myeloid neoplasms with t(16;21)(q24;q22)/RUNX1‐RUNX1T3 mimics acute myeloid leukemia with RUNX1‐RUNX1T1. Ann Hematol. 2018;97(10):1775‐1783.
-
- Kong XT, Ida K, Ichikawa H, et al. Consistent detection of TLS/FUS‐ERG chimeric transcripts in acute myeloid leukemia with t(16;21)(p11;q22) and identification of a novel transcript. Blood. 1997;90(3):1192‐1199.
-
- Döhner H, Wei AH, Appelbaum FR, et al. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood. 2022;140(12):1345‐1377.
-
- Alfayez M, Issa GC, Patel KP, et al. The clinical impact of PTPN11 mutations in adults with acute myeloid leukemia. Leukemia. 2021;35(3):691‐700.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
